Kura Oncology is a clinical-stage biopharmaceutical company dedicated to discovering and developing targeted therapies for blood cancers and solid tumors. The organization aims to revolutionize cancer treatment through precision medicine, utilizing a diverse pipeline of investigational drug candidates that focus on specific cancer signaling pathways. Kura's approach emphasizes rapidly translating novel scientific research into effective therapies to improve patient outcomes and enhance their quality of life. The company fosters a collaborative, patient-centric culture, valuing integrity, excellence, and innovative thinking among its employees. With offices in San Diego and Boston, Kura Oncology is committed to making a meaningful impact in the oncology space while cultivating a diverse and inclusive workplace.